Inhalers May Raise Blood Sugar: Are You at Risk?

Inhalers commonly treat lung conditions like asthma and COPD by opening airways or reducing inflammation. However, some of these medications can enter the bloodstream, potentially influencing glucose levels. This is a concern for individuals managing diabetes or monitoring their blood sugar.

Steroid-containing inhalers are of particular interest, as corticosteroids are known to affect glucose metabolism systemically. While inhaled corticosteroids are designed for local lung delivery, a fraction can be absorbed into circulation. The extent of this absorption depends on factors like drug potency and formulation.

Higher potency steroids and larger particle sizes tend to have greater systemic reach. This effect is usually modest compared to oral steroids. For most users, any rise in blood sugar is minor, but it can become clinically relevant for those with fragile glucose regulation.

The risk of blood sugar changes is greater with high-dose inhaled corticosteroids used long-term. Individuals with diabetes, prediabetes, or other metabolic risk factors are more susceptible. Older adults and those with prolonged exposure may also experience a clearer effect.

If an inhaler is suspected of raising blood sugar, closer monitoring is recommended rather than immediately stopping the medication. Keeping a log of inhaler timing alongside glucose readings can help identify patterns. Patients should discuss concerns with their doctor to adjust diabetes medication or explore alternative inhaler formulations or doses. Uncontrolled asthma or COPD poses serious risks, so respiratory control should not be compromised without medical advice.